Lifecome Biochemistry Co.,Ltd. (002868.SZ)

Growth (Per Share)

Revenue 5Y—
Revenue 3Y—
Earnings 5Y—
Earnings 3Y—
Dividend 5Y—
Dividend 3Y—

Capital Efficiency

ROIC—
ROE—
ROA—
ROTA—

Capital Structure

Market Cap4.91B
EV4.91B
Cash—
Current Ratio—
Debt/Equity—
Net Debt/EBITDA—
Show More

Select a metric from the list below to chart it

Income Statement
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
TTM
Revenue
43.1
56.2
58.5
54.7
50.1
44.2
44.9
52.9
48.0
53.5
Revenue % Chg.
-0.5%
30.4%
4.1%
-6.5%
-8.3%
-11.8%
1.4%
17.9%
-9.2%
16.7%
Cost of Revenue
30.6
35.4
35.5
32.6
32.8
29.5
31.3
44.2
49.4
54.1
Gross Profit
12.4
20.8
22.9
22.1
17.3
14.7
13.6
8.7
-1.3
-0.6
Gross Profit Margin
28.9%
37.0%
39.2%
40.4%
34.5%
33.3%
30.4%
16.4%
-2.8%
-1.1%
R&D Expenses
1.7
1.9
1.9
2.1
2.1
2.7
2.9
3.6
3.2
3.2
Selling, General, & Admin Expenses
2.7
3.6
3.7
3.6
3.5
3.5
2.5
2.9
2.4
3.0
Other Expenses
1.6
2.0
2.2
1.1
1.2
1.3
1.8
2.3
1.8
1.3
Operating Income
6.4
13.3
15.1
15.3
10.5
9.8
7.0
-3.1
-19.5
-16.8
Operating Income Margin
14.8%
23.7%
25.9%
28.0%
20.9%
22.1%
15.6%
-5.9%
-40.6%
-31.3%
Total Other Income/Expenses Net
-1.0
0.1
0.6
-0.7
2.2
-0.1
0.1
-1.6
-0.1
-2.7
Income Before Tax
5.3
13.4
15.8
14.6
12.7
9.6
7.1
-4.7
-19.5
-19.4
Income Before Tax Margin
12.4%
23.8%
27.0%
26.7%
25.3%
21.7%
15.7%
-8.9%
-40.7%
-36.3%
Income Tax Expense
0.8
2.0
2.3
2.1
1.8
1.3
0.8
-0.9
-1.7
-1.4
Net Income
4.6
11.4
13.5
12.5
10.9
8.3
6.3
-3.9
-17.9
-18.1
Net Income Margin
10.6%
20.3%
23.0%
22.9%
21.7%
18.8%
14.0%
-7.3%
-37.2%
-33.8%
Weighted Avg. Shares Out
116.8
116.7
116.6
143.2
156.6
154.0
154.3
153.2
154.4
149.1
EPS
0.0
0.1
0.1
0.1
0.1
0.1
0.0
-0.0
-0.1
-0.1
EPS % Chg.
-4.6%
148.6%
18.4%
-24.3%
-20.5%
-22.4%
-24.3%
—
370.6%
645.0%
Weighted Avg. Shares Out Dil
116.8
116.7
116.6
143.2
156.6
154.0
154.3
153.2
154.4
149.1
EPS Diluted
0.0
0.1
0.1
0.1
0.1
0.1
0.0
-0.0
-0.1
-0.1
Interest Income
0.0
0.0
0.0
0.0
0.0
0.0
0.2
0.1
0.0
0.0
Interest Expense
1.4
1.2
0.4
0.1
0.0
0.2
0.1
0.4
2.4
2.7
EBIT
4.0
12.2
15.4
14.6
12.7
9.5
7.1
-5.0
-21.9
-22.1
EBIT Margin
9.2%
21.7%
26.3%
26.7%
25.4%
21.4%
15.8%
-9.4%
-45.5%
-41.3%
Depreciation & Amortization
4.1
4.1
4.2
4.1
4.3
4.5
5.2
4.9
18.9
10.9
EBITDA
8.0
16.3
19.6
18.7
17.1
14.0
12.3
-0.1
-3.0
-11.3
EBITDA Margin
18.7%
29.0%
33.5%
34.2%
34.0%
31.6%
27.4%
-0.1%
-6.2%
-21.1%